Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

BackgroundImmune checkpoint inhibitors (ICIs) have improved survival for advanced wild-type non-small cell lung cancer (NSCLC) significantly, but few studies compared single ICI (SICI)-based treatments and double ICIs (DICI)-based treatments. We summarized the general efficacy of ICI-related treatme...

Full description

Bibliographic Details
Main Authors: Qian Xu, Xue Zhang, Miao Huang, Xin Dai, Jing Gao, Song Li, Lei Sheng, Kai Huang, Jian Wang, Lian Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
non-small cell lung cancer
first-line
immune checkpoint inhibitors
single
double
network meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.731546/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.731546/full

Similar Items